Skip to main content
. 2011 Jul 25;70(11):1914–1920. doi: 10.1136/ard.2011.151043

Figure 2.

Figure 2

Decline in co-medication with glucocorticoids in patients who received a dose of (A) 7.5–14 mg/day or (B) ≥15 mg/day. DMARD, disease-modifying antirheumatic drug; TNF, tumour necrosis factor.